9-101360970-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001701.4(BAAT):c.*1458G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 166,802 control chromosomes in the GnomAD database, including 2,130 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.15 ( 1989 hom., cov: 32)
Exomes 𝑓: 0.13 ( 141 hom. )
Consequence
BAAT
NM_001701.4 3_prime_UTR
NM_001701.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.291
Genes affected
BAAT (HGNC:932): (bile acid-CoA:amino acid N-acyltransferase) The protein encoded by this gene is a liver enzyme that catalyzes the transfer of C24 bile acids from the acyl-CoA thioester to either glycine or taurine, the second step in the formation of bile acid-amino acid conjugates. The bile acid conjugates then act as a detergent in the gastrointestinal tract, which enhances lipid and fat-soluble vitamin absorption. Defects in this gene are a cause of familial hypercholanemia (FHCA). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 9-101360970-C-T is Benign according to our data. Variant chr9-101360970-C-T is described in ClinVar as [Benign]. Clinvar id is 364254.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.199 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BAAT | NM_001701.4 | c.*1458G>A | 3_prime_UTR_variant | 4/4 | ENST00000259407.7 | ||
BAAT | NM_001127610.2 | c.*1458G>A | 3_prime_UTR_variant | 4/4 | |||
BAAT | NM_001374715.1 | c.*1458G>A | 3_prime_UTR_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BAAT | ENST00000259407.7 | c.*1458G>A | 3_prime_UTR_variant | 4/4 | 1 | NM_001701.4 | P1 | ||
ENST00000447628.2 | n.1308C>T | non_coding_transcript_exon_variant | 3/3 | ||||||
BAAT | ENST00000674791.1 | c.762+1953G>A | intron_variant, NMD_transcript_variant | ||||||
BAAT | ENST00000674909.1 | c.804+1911G>A | intron_variant, NMD_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.154 AC: 23438AN: 151980Hom.: 1985 Cov.: 32
GnomAD3 genomes
AF:
AC:
23438
AN:
151980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.128 AC: 1877AN: 14704Hom.: 141 Cov.: 0 AF XY: 0.129 AC XY: 1063AN XY: 8238
GnomAD4 exome
AF:
AC:
1877
AN:
14704
Hom.:
Cov.:
0
AF XY:
AC XY:
1063
AN XY:
8238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.154 AC: 23465AN: 152098Hom.: 1989 Cov.: 32 AF XY: 0.152 AC XY: 11268AN XY: 74340
GnomAD4 genome
AF:
AC:
23465
AN:
152098
Hom.:
Cov.:
32
AF XY:
AC XY:
11268
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
424
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hypercholanemia, familial 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at